Carregant...
Isradipine Versus Placebo in Early Parkinson Disease A Randomized Trial
BACKGROUND: Studies suggest that dihydropyridine calcium-channel blockers may be associated with reduced risk for Parkinson disease (PD). OBJECTIVE: To assess the effect of isradipine, a dihydropyridine calcium-channel blocker, on the rate of clinical progression of PD. DESIGN: Multicenter, randomiz...
Guardat en:
| Publicat a: | Ann Intern Med |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7465126/ https://ncbi.nlm.nih.gov/pubmed/32227247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M19-2534 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|